What would make you modify the approach described in A Sweet Solution to Oral Cancer Detection: The Diagnostic Lollipop?

DentalReach Evidence Review:

Shared decision-making should present realistic benefits, uncertainties, alternatives, maintenance needs and the consequence of no treatment. This is especially important when the evidence is early or the intervention is irreversible.

DentalReach Clinical Contributor:

The priority is a complete history and examination, a ranked differential diagnosis and explicit red-flag screening. Persistence, induration, neurological change or unexplained systemic findings should lower the threshold for investigation or referral.

DentalReach Practice Perspective:

A relevant next resource is Molecular Probing For Early Detection Of Oral Cancers — dentalreach.today/molecular-probing-for-early-detection-of-oral-cancers​. It adds a connected perspective for differential diagnosis, treatment selection or maintenance rather than functioning as an isolated “read more” link.

DentalReach Critical Appraisal:

Oral cancer ranks as the 13th most common cancer worldwide, with the World Health Organisation (WHO) estimating that in 2020 alone, there were 377,713. Its strongest use is as a structured starting point. Diagnosis, baseline risk, alternatives, likely benefit, potential harm and the patient’s priorities must still determine the final plan.